sTRBC1 and cyTRBC1 Expression Distinguishes Indolent T-Lymphoblastic Proliferations From T-Lymphoblastic Leukemia/Lymphoma.
暂无分享,去创建一个
Min Dong | Ling Zhong | Juan Liu | Mingyong Li | Jun Fu | Qian Xi | Xiaoming Fan | Gang Xu | Yanxin Li
[1] Mingyong Li,et al. Cytoplasmic TRBC1 Expression in T-ALL and AITL. , 2022, American journal of clinical pathology.
[2] A. Rosenwald,et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms , 2022, Leukemia.
[3] R. Warnke,et al. Indolent T‐lymphoblastic proliferation: A systematic review of the literature analyzing the epidemiologic, clinical, and pathologic features of 45 cases , 2022, International journal of laboratory hematology.
[4] N. Villamor,et al. High-Sensitive TRBC1-Based Flow Cytometric Assessment of T-Cell Clonality in Tαβ-Large Granular Lymphocytic Leukemia , 2022, Cancers.
[5] Xiaoge Zhou,et al. Indolent T-lymphoblastic proliferation: a report of three cases , 2021, Virchows Archiv.
[6] N. Villamor,et al. Anti-TRBC1 Antibody-Based Flow Cytometric Detection of T-Cell Clonality: Standardization of Sample Preparation and Diagnostic Implementation , 2021, Cancers.
[7] Ji Yuan,et al. Flow Cytometric Evaluation of Surface and Cytoplasmic TRBC1 Expression in the Differential Diagnosis of Immature T-Cell Proliferations. , 2021, American journal of clinical pathology.
[8] M. Loh,et al. Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma , 2021, Blood Advances.
[9] U. Johansson,et al. Emerging Role of T-cell Receptor Constant β Chain-1 (TRBC1) Expression in the Flow Cytometric Diagnosis of T-cell Malignancies , 2021, International journal of molecular sciences.
[10] F. Craig,et al. Utility of T-Cell Receptor β Constant Chain-1 Expression in the Diagnosis of Peripheral Blood Involvement by Cutaneous T-Cell Lymphoma. , 2020, The Journal of investigative dermatology.
[11] D. Jevremovic,et al. T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics , 2020, Modern Pathology.
[12] B. Wood,et al. Flow cytometric features of incidental indolent T lymphoblastic proliferations , 2020, Cytometry. Part B, Clinical cytometry.
[13] W. Schamel,et al. αβ and γδ T cell receptors: Similar but different , 2020, Journal of leukocyte biology.
[14] D. Jevremovic,et al. Single Antibody Detection of T‐Cell Receptor αβ Clonality by Flow Cytometry Rapidly Identifies Mature T‐Cell Neoplasms and Monotypic Small CD8‐Positive Subsets of Uncertain Significance , 2020, Cytometry. Part B, Clinical cytometry.
[15] N. Harris,et al. Follicular Dendritic Cell Sarcoma With Indolent T-Lymphoblastic Proliferation Is Associated With Paraneoplastic Autoimmune Multiorgan Syndrome , 2018, The American journal of surgical pathology.
[16] A. Bax,et al. The Role of Molecular Flexibility in Antigen Presentation and T Cell Receptor-Mediated Signaling , 2018, Front. Immunol..
[17] M. Piris,et al. Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies , 2017, Nature Medicine.
[18] R. Warnke,et al. Indolent T-lymphoblastic Proliferation With Disseminated Multinodal Involvement and Partial CD33 Expression , 2014, The American journal of surgical pathology.
[19] R. West,et al. TdT+ T-lymphoblastic Populations Are Increased in Castleman Disease, in Castleman Disease in Association With Follicular Dendritic Cell Tumors, and in Angioimmunoblastic T-cell Lymphoma , 2012, The American journal of surgical pathology.
[20] B. Nathwani,et al. Indolent T-lymphoblastic proliferation: report of a case with a 16-year course without cytotoxic therapy. , 1999, The American journal of surgical pathology.